Issn Print: 0003-4967
Publication Date: 2017/09/01
Response to: ‘Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease’ by Orlando et al
G Varkas; F Van den Bosch; D Elewaut
Author Information: Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.